Insights on supplement use during cancer care from online Reddit conversations
Barliz Waissengrin, Karen O’Connor, Celina H Shirazipour, Flores Amaro Ivan, Karen L Reckamp, Graciela Gonzalez-Hernandez, Jane C Figueiredo · 2026
Read Insights on supplement use during cancer care from online Reddit conversations by Barliz Waissengrin, Karen O’Connor, Celina H Shirazipour, Flores Amaro Ivan, Karen L Reckamp, Graciela Gonzalez-Hernandez, Jane C Figueiredo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13499959.txt.
Description
Barliz Waissengrin and colleagues mine in 2026 online conversations to learn how people with cancer actually use dietary supplements during treatment. Surveys often miss unfiltered patient motives, so the team turned to the Reddit community r/cancer, using language-processing tools to find supplement posts published between November 2010 and December 2022. From 1,488 matching posts they analysed a random tenth in depth, sorting posts by purpose, intended use, and supplement type.
Most sampled posts asked questions rather than reporting experience, and intent split almost evenly between treating the cancer itself and managing symptoms. Vitamins were the supplement named most often, and breast, lung, and colorectal cancers dominated among posters who named their disease. Fatigue, nausea, pain, and emotional distress drove much of the interest, often as strategies outside conventional care, which the authors say clinicians should raise openly in visits.
Catalog record
| CREATOR | Barliz Waissengrin, Karen O’Connor, Celina H Shirazipour, Flores Amaro Ivan, Karen L Reckamp, Graciela Gonzalez-Hernandez, Jane C Figueiredo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29778 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |